Cargando…
Estradiol Therapy in the Perioperative Period: Implications for Transgender People Undergoing Feminizing Hormone Therapy
Venous thromboembolism is a documented risk of some estradiol formulations, but evidence evaluating the perioperative risk of continuation of estradiol therapy is limited. This narrative review summarizes literature related to the perioperative venous thromboembolic risk of estradiol, with a focus o...
Autores principales: | Nolan, Brendan J., Cheung, Ada S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513447/ https://www.ncbi.nlm.nih.gov/pubmed/33005118 |
Ejemplares similares
-
Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia
por: Balcerek, Matthew I., et al.
Publicado: (2021) -
Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy
por: Nolan, Brendan J., et al.
Publicado: (2020) -
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study
por: Totaro, Maria, et al.
Publicado: (2021) -
An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy
por: Maheshwari, Arvind, et al.
Publicado: (2021) -
Facial Feminization Considerations for the Transgender Patient
por: Galbraith, Logan G., et al.
Publicado: (2023)